4-[2-(4-Hydroxy-3,5-dimethyl-phenyl)-vinyl]-benzoic acid | 127035-87-4

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: 4-[2-(4-Hydroxy-3,5-dimethyl-phenyl)-vinyl]-benzoic acid
• 英文别名: 4-[(E)-2-(4-hydroxy-3,5-dimethylphenyl)ethenyl]benzoic acid
• CAS: 127035-87-4
• 化学式: C₁₇H₁₆O₃
• 分子量: 268.312
• InChiKey: UCYPNXIEJDLIGN-ONEGZZNKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  3,5-二甲基-4-羟基苯甲醛 、 升对酞酸 在 哌啶 作用下， 以 二氯甲烷 为溶剂， 反应 7.0h， 生成 4-[2-(4-Hydroxy-3,5-dimethyl-phenyl)-vinyl]-benzoic acid
  参考文献：
  名称：

  Effect of structure on potency and selectivity in 2,6-disubstituted-4-(2-arylethenyl)phenol lipoxygenase inhibitors

  摘要：

  A series of 2,6-disubstituted 4-(2-arylethenyl)phenols with potent human neutrophil 5-lipoxygenase (5-LO) inhibiting activity (IC50S in the 10(-7) M range) and weaker human platelet cyclooxygenase (CO) inhibiting activity (IC50S in the 10(-6) M range) is described. This series evolved from the chemical modification of an antiinflammatory dual CO/5-LO inhibitor, 2,6-di-tert-butyl-4-[2-(3-pyridyl)ethenyl]phenol (BI-L-93 BS). The potency and selectivity for 5-LO inhibition is greatly influenced by the nature of the substituents in the 2- and 6-positions. Other structure-activity relationships that determine relative 5-LO and CO potency are discussed. In vivo activity against antigen-induced leukotriene-mediated bronchoconstriction and cell influx in guinea pigs is presented. Representatives of the series are active when administered at 30 mg/kg ip.

  DOI：

  10.1021/jm00169a010

文献信息

• SMALL MOLECULES THAT COVALENTLY MODIFY TRANSTHYRETIN
  申请人：Kelly Jeffery W.

  公开号：US20120270938A1

  公开（公告）日：2012-10-25

  A family of covalent kinetic stabilizer compounds that selectively and covalently react with the prominent plasma protein transthyretin in preference to more than 4000 other human plasma proteins is disclosed. A contemplated compound corresponds in structure to Formula I, below, where the various substituents are defined within, and reacts chemoselectively with one or two of four Lys-15 ε-amino groups within the transthyretin tetramer. The crystal structure confirms the binding orientation of the compound substructure and the conjugating amide bond. A covalent transthyretin kinetic stabilizer exhibits superior amyloid inhibition potency, compared to a non-covalent counterpart, and inhibits cytotoxicity associated with amyloidogenesis.

  本文介绍了一类共价动力稳定剂化合物家族，它们选择性地、共价地与突出的血浆蛋白转甲状腺素结合，而不是其他4000多种人类血浆蛋白。一种可考虑的化合物对应于以下的结构式I，其中各取代基在内部定义，并与转甲状腺素四聚体中的一个或两个Lys-15 ε-氨基基团发生化学选择性反应。晶体结构证实了化合物亚结构和结合酰胺键的结合方向。与非共价对应物相比，共价转甲状腺素动力稳定剂表现出优越的淀粉样抑制效能，并抑制与淀粉样生成相关的细胞毒性。
• Small Molecules That Covalently Modify Transthyretin
  申请人：Kelly Jeffery W.

  公开号：US20140336254A1

  公开（公告）日：2014-11-13

  A family of covalent kinetic stabilizer compounds that selectively and covalently react with the prominent plasma protein transthyretin in preference to more than 4000 other human plasma proteins is disclosed. A contemplated compound corresponds in structure to Formula I, below, where the various substituents are defined within, and reacts chemoselectively with one or two of four Lys-15 ε-amino groups within the transthyretin tetramer. The crystal structure confirms the binding orientation of the compound substructure and the conjugating amide bond. A covalent transthyretin kinetic stabilizer exhibits superior amyloid inhibition potency, compared to a non-covalent counterpart, and inhibits cytotoxicity associated with amyloidogenesis.

  本发明揭示了一种共价动力稳定剂化合物家族，它们选择性地和共价地与显著的血浆蛋白转甲状腺素反应，而不是其他4000多种人类血浆蛋白。考虑到的化合物对应于以下公式I的结构，其中各种取代基在内部定义，并与转甲状腺素四聚体内的四个Lys-15 ε-氨基基团之一或两个发生化学选择性反应。晶体结构证实了化合物亚结构和结合酰胺键的结合方向。与非共价对应物相比，共价转甲状腺素动力稳定剂表现出优越的淀粉样抑制效力，并抑制与淀粉样生成相关的细胞毒性。
• Liquid crystalline polyesters, their composition, and their uses
  申请人：NIPPON OIL CO., LTD.

  公开号：EP0905164A2

  公开（公告）日：1999-03-31

  There are provided liquid crystalline polyesters comprising 4'-hydroxy-4-stilbenecarboxylic acid type units, dicarboxylic acid units acting as a mesogen such as 4,4'-stilbenecarboxylic acid and catechol units as essential ingredients, and a liquid crystalline polyester composition comprising said polyesters and optically active liquid crystalline polyesters consisting essentially of 4,4'-stilbenedicarboxylic acid type units and aliphatic diol units having asymmetric carbons.

  提供了由 4'-羟基-4-二苯甲酸型单元、作为中间体的二羧酸单元（如 4,4'-二苯甲酸和邻苯二酚单元）作为基本成分组成的液晶聚酯，以及由上述聚酯和主要由 4,4'-二苯甲酸型单元和具有不对称碳原子的脂肪族二元醇单元组成的光学活性液晶聚酯组成的液晶聚酯组合物。
• Liquid crystalline polyester compositions and their uses
  申请人：Nippon Mitsubishi Oil Corporation

  公开号：EP0905164B1

  公开（公告）日：2006-05-03
• US5989758A
  申请人：——

  公开号：US5989758A

  公开（公告）日：1999-11-23